Literature DB >> 12917926

Timing and volume of fluid administration for patients with bleeding.

I Kwan, F Bunn, I Roberts.   

Abstract

BACKGROUND: Treatment of haemorrhagic shock involves maintaining blood pressure and tissue perfusion until bleeding is controlled. Different resuscitation strategies have been used to maintain the blood pressure in trauma patients until bleeding is controlled. However, while maintaining blood pressure may prevent shock, it may worsen bleeding.
OBJECTIVES: To assess the effects of early versus delayed, and larger versus smaller volume of fluid administration in trauma patients with bleeding. SEARCH STRATEGY: We searched the Cochrane Controlled Trials Register, the specialised register of the Injuries Group, MEDLINE, EMBASE, the National Research Register and the Science Citation Index. We checked reference lists of identified articles and contacted authors and experts in the field. SELECTION CRITERIA: Randomised trials of the timing and volume of intravenous fluid administration in trauma patients with bleeding. Trials in which different types of intravenous fluid were compared were excluded. DATA COLLECTION AND ANALYSIS: Two reviewers independently extracted data and assessed trial quality. MAIN
RESULTS: We did not combine the results quantitatively because the interventions and patient populations were so diverse. Early versus delayed fluid administration. Three trials reported mortality and two coagulation data. In the first trial (n=598) relative risk (RR) for death with early fluid administration was 1.26 (95% confidence interval of 1.00-1.58). The weighted mean differences (WMD) for prothrombin time and partial thromboplastin time were 2.7 (95% CI 0.9-4.5) and 4.3 (95% CI 1.74-6.9) seconds respectively. In the second trial (n=50) RR for death with early blood transfusion was 5.4 (95% CI 0.3-107.1). The WMD for partial thromboplastin time was 7.0 (95% CI 6.0-8.0) seconds. In the third trial (n=1309) RR for death with early fluid administration was 1.06 (95% CI 0.77-1.47). Larger versus smaller volume of fluid administration. Three trials reported mortality and one coagulation data. In the first trial (n=36) RR for death with a larger volume of fluid resuscitation was 0.80 (95% CI 0.28-22.29). Prothrombin time and partial thromboplastin time were 14.8 and 47.3 seconds in those who received a larger volume of fluid, as compared to 13.9 and 35.1 seconds in the comparison group. In the second trial (n=110) RR for death with a high systolic blood pressure resuscitation target (100mmHg) maintained with a larger volume of fluid, as compared to low systolic blood pressure resuscitation target (70mmHg) maintained with a smaller volume of fluid was 1.00 (95% CI 0.26-3.81). In the third trial (n=25) there were no deaths. REVIEWER'S
CONCLUSIONS: We found no evidence from randomised controlled trials for or against early or larger volume of intravenous fluid administration in uncontrolled haemorrhage. There is continuing uncertainty about the best fluid administration strategy in bleeding trauma patients. Further randomised controlled trials are needed to establish the most effective fluid resuscitation strategy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12917926     DOI: 10.1002/14651858.CD002245

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  36 in total

1.  Part 10: Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.

Authors:  Monica E Kleinman; Allan R de Caen; Leon Chameides; Dianne L Atkins; Robert A Berg; Marc D Berg; Farhan Bhanji; Dominique Biarent; Robert Bingham; Ashraf H Coovadia; Mary Fran Hazinski; Robert W Hickey; Vinay M Nadkarni; Amelia G Reis; Antonio Rodriguez-Nunez; James Tibballs; Arno L Zaritsky; David Zideman
Journal:  Circulation       Date:  2010-10-19       Impact factor: 29.690

2.  Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations.

Authors:  Monica E Kleinman; Allan R de Caen; Leon Chameides; Dianne L Atkins; Robert A Berg; Marc D Berg; Farhan Bhanji; Dominique Biarent; Robert Bingham; Ashraf H Coovadia; Mary Fran Hazinski; Robert W Hickey; Vinay M Nadkarni; Amelia G Reis; Antonio Rodriguez-Nunez; James Tibballs; Arno L Zaritsky; David Zideman
Journal:  Pediatrics       Date:  2010-10-18       Impact factor: 7.124

3.  Selective histone deacetylase 6 inhibition prolongs survival in a lethal two-hit model.

Authors:  Xin Cheng; Zhengcai Liu; Baoling Liu; Ting Zhao; Yongqing Li; Hasan B Alam
Journal:  J Surg Res       Date:  2015-03-06       Impact factor: 2.192

Review 4.  [Treatment of hemorrhagic shock. New therapy options].

Authors:  W G Voelckel; A von Goedecke; D Fries; A C Krismer; V Wenzel; K H Lindner
Journal:  Anaesthesist       Date:  2004-12       Impact factor: 1.041

5.  The effects of commonly used resuscitation fluids on whole blood coagulation.

Authors:  T J Coats; E Brazil; M Heron
Journal:  Emerg Med J       Date:  2006-07       Impact factor: 2.740

6.  Hypoxia and hypotension, the "lethal duo" in traumatic brain injury: implications for prehospital care.

Authors:  Philip F Stahel; Wade R Smith; Ernest E Moore
Journal:  Intensive Care Med       Date:  2007-10-16       Impact factor: 17.440

7.  [Targeted cardiovascular therapy: shock treatment in ambulance, emergency room and intensive care unit].

Authors:  S Kluge; G Kreymann
Journal:  Internist (Berl)       Date:  2006-04       Impact factor: 0.743

8.  New trends in resuscitation.

Authors:  Hasan B Alam; George C Velmahos
Journal:  Curr Probl Surg       Date:  2011-08       Impact factor: 1.909

9.  Before-after study of a restricted fluid infusion strategy for management of donor hepatectomy for living-donor liver transplantation.

Authors:  Yoshihito Fujita; Akinori Takeuchi; Takeshi Sugiura; Tomonori Hattori; Nobuko Sasano; Yuichiro Mizuochi; Kazuya Sobue
Journal:  J Anesth       Date:  2009-02-22       Impact factor: 2.078

10.  Defying Death.

Authors:  Hasan B Alam
Journal:  Crit Care Med       Date:  2015-12       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.